95 results
8-K
EX-10.3
PMCB
PharmaCyte Biotech Inc
23 May 24
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical
4:40pm
8-K
EX-10.4
PMCB
PharmaCyte Biotech Inc
23 May 24
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical
4:40pm
8-K
EX-10.1
PMCB
PharmaCyte Biotech Inc
23 May 24
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical
4:40pm
8-K
EX-10.2
PMCB
PharmaCyte Biotech Inc
23 May 24
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical
4:40pm
8-K
EX-10.5
PMCB
PharmaCyte Biotech Inc
23 May 24
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical
4:40pm
8-K
EX-10.1
lrqa0as9d3s
15 Nov 23
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value
8:45pm
8-K
EX-10.3
oillk1v
15 Nov 23
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value
8:45pm
8-K
EX-10.2
v7tmj8q
15 Nov 23
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value
8:45pm
8-K
EX-10.4
iqk4g
15 Nov 23
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value
8:45pm
8-K
EX-10.1
redrjw9jy5 htuqa
11 May 23
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000
8:30am
8-K
EX-10.3
9h9n a6ho1gkidtzhd
11 May 23
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000
8:30am
8-K
EX-10.2
74szeju09 ppsn
11 May 23
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000
8:30am
8-K
EX-10.1
1fnyzyvm
14 Oct 22
Departure of Directors or Certain Officers
4:12pm
8-K
EX-10.1
utget6k
7 Oct 22
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
4:53pm
8-K
EX-10.1
96o0lxmwg6rst 2k
15 Aug 22
Company Appoints Five New Independent Directors to Reconstituted Board
6:55pm
8-K
EX-10.2
l10xe3
15 Aug 22
Company Appoints Five New Independent Directors to Reconstituted Board
6:55pm
DEFA14A
EX-10.2
c3e 75etdkggwn
15 Aug 22
Additional proxy soliciting materials
6:53pm
DEFA14A
EX-10.1
fu4mz2
15 Aug 22
Additional proxy soliciting materials
6:53pm